Skip to content

GH Research

US · GHRS #2969 by market cap Listed 2021
17.53 -1.03 -5.55%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44
    Market Newswire · 2026/8/31
  • H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
    Market Newswire · 2026/11/9
  • Rating change
    A Quick Look at Today's Ratings for GH Research(GHRS.US), With a Forecast Between $32 to $39
    Market Newswire · 2026/5/15
  • Rating change
    Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION)
    TipRanks · 2026/3/7
  • Rating change
    RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/5/16
  • Rating change
    Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $35
    Market Newswire · 2026/5/16
  • Rating change
    Wells Fargo Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $44
    Market Newswire · 2026/7/27
  • Rating change
    Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $39
    Market Newswire · 2026/8/7
  • Rating change
    H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $65
    Market Newswire · 2026/5/19
  • Rating change
    Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $34
    Market Newswire · 2026/3/10
  • Rating change
    Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/8/7
  • Rating change
    H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)
    TipRanks · 2026/4/29
  • Rating change
    Stifel Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/3/6
  • RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $42
    Market Newswire · 2026/11/10
  • CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
    Market Newswire · 2026/8/8
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), MapLight Therapeutics, Inc. (MPLT)
    TipRanks · 2026/5/15
  • Rating change
    H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/4/29
  • Rating change
    Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/8/7
  • TD Cowen Maintains GH Research(GHRS.US) With Buy Rating
    Market Newswire · 2026/8/7
  • Rating change
    Citizens JMP Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $42
    Market Newswire · 2026/3/6
  • Rating change
    Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $32
    Market Newswire · 2026/3/6
  • H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
    Market Newswire · 2026/8/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

GH Research discussion 0 comments

Add a comment